Trial Profile
Effects of long-term administration of low-dose adefovir dipivoxil and lamivudine in patients with chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Adefovir dipivoxil (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 21 Dec 2015 New trial record